| INTRODUCTION
Breast cancer is a kind of heterogeneous disease, being classified into distinct subtypes based on the molecular markers variants. Triple-negative breast cancer (TNBC), characterized by the absence of the oestrogen receptor (ER), the progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) expression, was known as the most aggressive breast cancer subtype.
1 TNBC patients have a higher risk of distant metastasis and a poorer overall survival than other breast cancer patients, partly due to lacking effective targeted therapies. 2 Despite the great effort made on researching TNBC, the molecular mechanisms underlying TNBC aggressive behaviour are still obstacles to TNBC treatment.
MicroRNAs (miRNAs) are small non-coding RNAs that function through binding to the 3′-untranslated region (3′-UTR) of target mRNAs, resulting in mRNA degradation or translation inhibition. [3] [4] [5] Increasing evidence has revealed that deregulated miRNAs are repression with DNMT3A-mediated DNA methylation, which is crucial for digging out the mechanisms of DNA methylation in regulating miRNAs. 22 Previous studies have demonstrated that the activation of MYC proto-oncogene, bHLH transcription factor (MYC) gene contributes to cancer genesis. 23, 24 However, the roles of MYC in epigenetically regulating miRNAs are largely unclear. In this study, we aimed to reveal the mechanism of MYC and DNMT3A inducing miR-200b
repression, which was involved in EMT and mammosphere formation of TNBC cells. 
| MATERIALS AND METHODS

| Cell culture and treatment
| Tissue specimens
All tissue samples (ER+, n = 20; ER-PR-HER2+, n = 13; TNBC, n = 31) used in this study were obtained from patients of the First Hospital (XJTU1AF2016LSK-05) and a written informed consent document was signed by each participant. The specimens were resected and frozen in liquid nitrogen immediately after surgery.
None of the patients had received any chemotherapy or radiation therapy prior to the study. Clinicopathologic characteristics of the patients were shown in Table S1 . of the target genes were analysed using the comparative threshold cycle (2 −ΔΔCt ) method as previously described. 25 The primers for real-time PCR are provided in Table S2 .
| Immunofluorescence and immunohistochemistry staining
The cells were fixed in 4% formaldehyde in PBS for 15 At least six clones were subjected to sequencing analyses (Invitrogen, Shanghai, China).
| Dual-Luciferase Reporter
The 
| Co-immunoprecipitation assays
Co-immunoprecipitation was conducted as preciously described. 26 Briefly, cells were rinsed with ice-cold PBS and lysed in RIPA buffer.
The cells lysates were pre-cleared by adding 100 μL of Protein A/G agarose beads, and then subjected to overnight incubation with specific antibodies anti-MYC antibody (N262; Santa Cruz Biotechnology) or anti-DNMT3A antibody (IMG268; Imgenex). Immunocomplexes were precipitated by incubating with Protein A/G agarose beads, followed by washing with ice-cold lysis buffer. Subsequently, the agarose beads with immune complexes were boiled in 2× SDS sample buffer. Then, the immune complexes were analysed by western blotting.
| Chromatin immunoprecipitation assay
Chromatin immunoprecipitation (ChIP) was performed as previously described with minor modification. 18, 26 Briefly, cells were cross-linked with 1% formaldehyde at 37°C for 10 minutes. After removing the medium, cells were resuspended in 100 μL lysis buffer per 1 × 10 6 cells and lysed on ice for 15 minutes. Then, the samples were sonicated to shear chromatin to fragments ranging from 200 to 1000 base pairs.
Subsequently, the chromatin fragments were used for immunoprecipitation with antibodies as follows: anti-MYC antibody (N262; Santa Cruz Biotechnology) and anti-DNMT3A antibody (IMG268; Imgenex). The primers used for PCR analysis for the proximal promoter region of the miR-200b were as follows: forward primer, 5′-CACCGCCTCC-CATTGTC-3′; reverse primer, 5′-CACAGGAAGTCAGTTCAGACC-3′.
| Sphere-formation assays
Mammospheres were cultured as we previously described. 
| Migration and invasion assays
The cells were planted in six-well plates and transfected as indicated. 
| Statistical analysis
All statistical analyses were performed with SPSS software (version 18.0; SPSS Inc., Chicago, IL, USA). All data were represented as mean ± SD from at least three independent experiments. The statistical significance in mean values was determined with Student's ttest (two-tailed). For skewed distribution data, statistical significance was determined with nonparametric test. P < 0.05 indicated a statistically significant difference. However, MYC and DNMT3A levels in breast cancer cell lines did not show a significant subtype-specific signature ( Figure S1B and C). In addition, there was no significant difference in miR200b promoter methylation levels among the breast cancer subtypes according to TCGA methylation database ( Figure S1D ). As a transcription factor, MYC can promote some target genes expression by dimerizing with Max, and repress others through interacting with Miz-1, Sp1 and Smad2. [37] [38] [39] Recent studies have shown that MYC is associated with epigenetic regulators in silencing miRNAs.
| DNMT3A knockdown induces miR-200b expression via promoter demethylation
In hepatocellular carcinoma, MYC repressed miR-101 expression by recruiting EZH2 to the promoter regions of miR-101. 40 During Helicobacter pylori-related carcinogenesis, MYC, DNMT3B and EZH2 interacted with each other and led to let-7c silencing by inducing histone methylation and DNA hypermethylation. 41 However, the role of MYC in epigenetically regulating miR-200 expression is still unclear.
A previous study has demonstrated that MYC represses p21Cip1 transcription through recruitment of DNMT3A. 42 MYC directly binds to and represses the miR-200b promoter in endometrial carcinoma cells. 43 Furthermore, DNMT3A knockdown increases miR-200b
expression. 44 Then, we wondered whether MYC is responsible for Moreover, we demonstrated miR-200b directly inhibited DNMT3A expression and then formed a feedback loop, which contributed to further miR-200b repression and DNMT3A overexpression by a self-reinforcing system. 46 We also try to validate the 
